US Taxpayers Heavily Funded the Discovery of COVID‐19 Vaccines-Reference-Cited by-同舟云学术

US Taxpayers Heavily Funded the Discovery of COVID‐19 Vaccines

Published:2021-07-09 Issue:3 Volume:111 Page:542-544
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Lalani Hussain S.¹²,Avorn Jerry²³,Kesselheim Aaron S.²³

Affiliation:

1. Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA

2. Program on Regulation, Therapeutics, and Law Division of Pharmacoepidemiology and Pharmacoeconomics Department of Medicine Brigham and Women’s Hospital Boston Massachusetts USA

3. Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2344

Reference10 articles.

1. Kennedy D.This scientist’s decades of mRNA research led to both COVID‐19 vaccines. New York Post. December 5 2020 .

2. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

3. Gelles D.The Husband‐and‐Wife team behind the leading vaccine to solve Covid‐19. New York Times. November 10 2020 .

4. Pre-fusion structure of a human coronavirus spike protein

5. Allen A.Government‐funded scientists laid the groundwork for billion‐dollar vaccines. Kaiser Health News. November 18 2020 .

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. For the good of the people: establishing public value creation as an objective for sustainable entrepreneurship policy;International Journal of Entrepreneurial Venturing;2024

2. From Emergence to Endemicity: A Comprehensive Review of COVID-19;Cureus;2023-10-31

3. Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies;Health Policy;2023-08

4. US public investment in development of mRNA covid-19 vaccines: retrospective cohort study;BMJ;2023-03-01

5. Global and regional governance of One Health and implications for global health security;The Lancet;2023-02